Historical record - last NADAC effective date: 2/22/2023
Product Information
ENOXAPARIN 150 MG/ML SYRINGE is a generic product labeled by Fresenius Kabi USA, LLC, priced at $15.3321 per ML under NDC 63323053784. Its NADAC has been published 153 times since Apr 1, 2020.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
Strength
150 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323053784
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
2/22/2023
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 150 MG/ML SYRINGE has been published 153 times since Apr 1, 2020, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.3321 per ML |
|---|---|
| All-time high | $19.8830 (Feb 15, 2023) |
| All-time low | $11.4021 (Nov 18, 2020) |
| Median price | $12.7390 |
| Average price | $13.4217 |
| Largest weekly change | +27.5% (Aug 17, 2022) |
| Weeks tracked | 153 |
| Tracking since | Apr 1, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+20.7%
All
+9.9%
Last surveyed Mar 1, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
enoxaparin sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 150 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 150 MG/ML SYRINGE, manufactured by Fresenius Kabi USA, LLC, is $15.3321 per ML (NDC 63323053784), effective Mar 1, 2023.
How has the price of ENOXAPARIN 150 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 150 MG/ML SYRINGE has risen 9.9%. It has been tracked across 153 weekly CMS publications since Apr 1, 2020.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 150 MG/ML SYRINGE?
Since Apr 1, 2020, the NADAC for ENOXAPARIN 150 MG/ML SYRINGE has ranged from a low of $11.4021 (Nov 18, 2020) to a high of $19.8830 (Feb 15, 2023), with a median of $12.7390 per ML.
Are there cheaper alternatives to ENOXAPARIN 150 MG/ML SYRINGE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENOXAPARIN 150 MG/ML SYRINGE, is $8.9038 per ML — about 42% below ENOXAPARIN 150 MG/ML SYRINGE.
Who manufactures ENOXAPARIN 150 MG/ML SYRINGE?
ENOXAPARIN 150 MG/ML SYRINGE (NDC 63323053784) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.